FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bror Morein

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Co-author Network

Publications

TOP 3
Cecilia M Camussone; Iván S Marcipar; Bror Morein; Carina Porporatto; Carolina M Veaute; Luis F Calvinho
Immune response of heifers against a Staphylococcus aureus CP5 whole cell vaccine formulated with ISCOMATRIX™ adjuvant.
Saadia B Hassan; Kefei Hu; Bror Morein; Saideh Berenjian; Joachim Gullbo; Peter Nygren
The Nanoparticulate Quillaja Saponin BBE is selectively active towards renal cell carcinoma.
Karin Lövgren-Bengtsson; Bror Morein; Albert Dme Osterhaus
ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bror Morein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cecilia M Camussone; Iván S Marcipar; Bror Morein; Carina Porporatto; Carolina M Veaute; Luis F Calvinho
Immune response of heifers against a Staphylococcus aureus CP5 whole cell vaccine formulated with ISCOMATRIX™ adjuvant.
The Journal of dairy research 2013;80(1):72-80.
2013: Saadia B Hassan; Kefei Hu; Bror Morein; Saideh Berenjian; Joachim Gullbo; Peter Nygren
The Nanoparticulate Quillaja Saponin BBE is selectively active towards renal cell carcinoma.
Anticancer research 2013;33(1):143-51.
2011: Karin Lövgren-Bengtsson; Bror Morein; Albert Dme Osterhaus
ISCOM technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation.
Expert review of vaccines 2011;10(4):401-3.
2010: Marli S P Azevedo; Ana M Gonzalez; Lijuan Yuan; Kwang-il Jeong; Cristiana Iosef; Trang Van Nguyen; Karin Lovgren-Bengtsson; Bror Morein; Linda J Saif
An oral versus intranasal prime/boost regimen using attenuated human rotavirus or VP2 and VP6 virus-like particles with immunostimulating complexes influences protection and antibody-secreting cell responses to rotavirus in a neonatal gnotobiotic pig model.
Clinical and vaccine immunology : CVI 2010;17(3):420-8.
2010: Kefei Hu; Saideh Berenjian; Rolf Larsson; Joachim Gullbo; Peter Nygren; Tanja Lövgren; Bror Morein
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index.
International journal of nanomedicine 2010;5():51-62.
2007: Bror Morein; Gunilla A M Blomqvist; K Hu
Immune responsiveness in the neonatal period.
Journal of comparative pathology 2007;137 Suppl 1():S27-31.
2007: Gerrit Koopman; Willy M J M Bogers; ME van Gils; Wim Koornstra; Susan Barnett; Bror Morein; Thomas Lehner; Jonathan Luke Heeney
Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
Journal of medical virology 2007;79(5):474-82.
2006: Trang V Nguyen; Lijuan Yuan; Marli S P Azevedo; Kwang-il Jeong; Ana M Gonzalez; Cristiana Iosef; Karin Lovgren-Bengtsson; Bror Morein; Peggy Lewis; Linda J Saif
High titers of circulating maternal antibodies suppress effector and memory B-cell responses induced by an attenuated rotavirus priming and rotavirus-like particle-immunostimulating complex boosting vaccine regimen.
Clinical and vaccine immunology : CVI 2006;13(4):475-85.
2006: Trang V Nguyen; Lijuan Yuan; Marli S P Azevedo; Kwang-il Jeong; Ana M Gonzalez; Cristiana Iosef; Karin Lovgren-Bengtsson; Bror Morein; Peggy Lewis; Linda J Saif
Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine.
Vaccine 2006;24(13):2302-16.
2005: Ke-Fei Hu; Matthias Regner; Claire-Anne Siegrist; Paul Lambert; Margaret Chen; Karin Lövgren Bengtsson; Bror Morein
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703.
FEMS immunology and medical microbiology 2005;43(2):269-76.
2004: Sara Hägglund; Ke-Fei Hu; Lars Larsen; Mikhayil Hakhverdyan; Jean-François Valarcher; Geraldine Taylor; Bror Morein; Sándor Belák; Stefan Alenius
Bovine respiratory syncytial virus ISCOMs--protection in the presence of maternal antibodies.
Vaccine 2004;23(5):646-55.
2004: Bror Morein; Ke-Fei Hu; Izzeldin Abusugra
Current status and potential application of ISCOMs in veterinary medicine.
Advanced drug delivery reviews 2004;56(10):1367-82.
2004: Matthias Regner; Fiona Culley; Paola Fontannaz; Kefei Hu; Bror Morein; Paul-Henri Lambert; Peter Openshaw; Claire-Anne Siegrist
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infection.
Microbes and infection / Institut Pasteur 2004;6(7):666-75.
2004: Petra Mooij; Ivonne G Nieuwenhuis; Christiaan J Knoop; Robert W Doms; Willy M J M Bogers; Peter Ten Haaft; Henk Niphuis; Wim Koornstra; Kurt Bieler; Josef Köstler; Bror Morein; Aurelio Aurelio Cafaro; Barbara Ensoli; Ralf Wagner; Jonathan Luke Heeney
Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
Journal of virology 2004;78(7):3333-42.
2004: A M González; Trang V Nguyen; Marli S P Azevedo; Kwang il Jeong; F Agarib; Cristiana Iosef; K Chang; Karin Lovgren-Bengtsson; Bror Morein; Linda J Saif
Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.
Clinical and experimental immunology 2004;135(3):361-72.
2004: David Davis; Helen Donners; Betty Willems; Karin Lövgren-Bengtsson; Lennart Akerblom; Guido Vanham; Susan Barnett; Bror Morein; Jonathan Luke Heeney; Guido van der Groen
Neutralization of primary HIV-1 SF13 can be detected in extended incubation phase assays with sera from monkeys immunized with recombinant HIV-1 SF2 gp120.
Vaccine 2004;22(5-6):747-54.
2003: Trang V Nguyen; Cristiana Iosef; Kwang il Jeong; Yunjeong Kim; Kyeong-Ok Chang; Karin Lovgren-Bengtsson; Bror Morein; Marli S P Azevedo; Peggy Lewis; P Nielsen; Lijuan Yuan; Linda J Saif
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs.
Vaccine 2003;21(25-26):4059-70.
2003: O J B Hübschle; Georgina Tjipura-Zaire; Izzeldin Abusugra; G di Francesca; F Mettler; A Pini; Bror Morein
Experimental field trial with an immunostimulating complex (ISCOM) vaccine against contagious bovine pleuropneumonia.
Journal of veterinary medicine. B, Infectious diseases and veterinary public health 2003;50(6):298-303.
2003: Gunilla A M Blomqvist; Karin Lövgren-Bengtsson; Bror Morein
Influence of maternal immunity on antibody and T-cell response in mice.
Vaccine 2003;21(17-18):2022-31.
2002: Margaret Chen; Ke-Fei Hu; Björn Rozell; Claes Orvell; Bror Morein; Peter Liljeström
Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(6):3208-16.
2002: Bror Morein; Izzeldin Abusugra; Gunilla A M Blomqvist
Immunity in neonates.
Veterinary immunology and immunopathology 2002;87(3-4):207-13.
2002: Gunilla A M Blomqvist; Krister Martin; Bror Morein
Transmission pattern of parainfluenza 3 virus in guinea pig breeding herds.
Contemporary topics in laboratory animal science / American Association for Laboratory Animal Science 2002;41(4):53-7.
2002: Cristiana Iosef; Trang Van Nguyen; Kwang il Jeong; Karin Lövgren Bengtsson; Bror Morein; Yunjeong Kim; Kyeong-Ok Chang; Marli S P Azevedo; Lijuan Yuan; Paul Nielsen; Linda J Saif
Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes.
Vaccine 2002;20(13-14):1741-53.
2001: Ke-Fei Hu; Karin Lövgren-Bengtsson; Bror Morein
Immunostimulating complexes (ISCOMs) for nasal vaccination.
Advanced drug delivery reviews 2001;51(1-3):149-59.
2001: Ke-Fei Hu; Margaret Chen; Izzeldin Abusugra; F Monaco; Bror Morein
Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profiles.
FEMS immunology and medical microbiology 2001;31(2):105-12.
1999: S Behboudi; Bror Morein; Maria Villacres
Quillaja saponin formulations that stimulate proinflammatory cytokines elicit a potent acquired cell-mediated immunity.
Scandinavian journal of immunology 1999;50(4):371-7.
1999: Bror Morein; Karin Lövgren Bengtsson
Immunomodulation by iscoms, immune stimulating complexes.
Methods (San Diego, Calif.) 1999;19(1):94-102.
1999: Ernst J Verschoor; David Davis; ME van Gils; Gerrit Koopman; Petra Mooij; Herman Oostermeijer; Peter Ten Haaft; Babs E Verstrepen; Brigitte Rosenwirth; Bror Morein; Susan W Barnett; Jonathan Luke Heeney
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus.
Journal of medical primatology 1999;28(4-5):224-32.
1999: J Ekström; Ke-Fei Hu; Karin Lövgren Bengtsson; Bror Morein
Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions.
Vaccine 1999;17(20-21):2690-701.
1999: Ke-Fei Hu; J Ekström; Malik Merza; Karin Lövgren-Bengtsson; Bror Morein
Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes.
Medical microbiology and immunology 1999;187(4):191-8.
1999: Ernst J Verschoor; Petra Mooij; Herman Oostermeijer; M van der Kolk; Peter Ten Haaft; Babs E Verstrepen; Y Sun; Bror Morein; Lennart Akerblom; Deborah H Fuller; Susan W Barnett; Jonathan Luke Heeney
Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.
Journal of virology 1999;73(4):3292-300.
1999: A Douglas Wilson; Karin Lövgren-Bengtsson; M Villacres-Ericsson; Bror Morein; Andrew J Morgan
The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines.
Vaccine 1999;17(9-10):1282-90.
1999: Jonathan Luke Heeney; Lennart Akerblom; Susan Barnett; Willy M J M Bogers; David Davis; D Fuller; Gerrit Koopman; Thomas Lehner; Petra Mooij; Bror Morein; Carlo De Giuli Morghen; Brigitte Rosenwirth; Ernst J Verschoor; Ralf Wagner; H Wolf
HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.
Immunology letters 1999;66(1-3):189-95.
1999: Izzeldin Abusugra; Bror Morein
Iscom is an efficient mucosal delivery system for Mycoplasma mycoides subsp. mycoides (MmmSC) antigens inducing high mucosal and systemic antibody responses.
FEMS immunology and medical microbiology 1999;23(1):5-12.
1999: Bror Morein; M Villacrés-Eriksson; J Ekström; K Hu; S Behboudi; Karin Lövgren-Bengtsson
ISCOM: a delivery system for neonates and for mucosal administration.
Advances in veterinary medicine 1999;41():405-13.
1998: Jonathan Luke Heeney; Vera J P Teeuwsen; ME van Gils; Willy M J M Bogers; Carlo De Giuli Morghen; Antonia Radaelli; Susan Barnett; Bror Morein; Lennart Akerblom; Y Wang; Thomas Lehner; David Davis
beta-chemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(18):10803-8.
1998: Ke-Fei Hu; M Elvander; Malik Merza; Lennart Akerblom; A Brandenburg; Bror Morein
The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses.
Clinical and experimental immunology 1998;113(2):235-43.
1998: Ke-Fei Hu; Bror Morein; Malik Merza
Using distilled water for the extraction of mucosal antibodies and the subsequent application in RSV neutralization test.
Journal of immunoassay 1998;19(2-3):209-22.
1998: Diana Hansen; Maria Villacres; Lennart Akerblom; U Hellman; E Segura; M Carlomagno; Bror Morein
An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-beta-mediated mechanism.
Scandinavian journal of immunology 1998;47(5):509-16.
1998: Suryaprakash Sambhara; S Woods; R Arpino; A Kurichh; A Tamane; BJ Underdown; M Klein; Karin Lövgren-Bengtsson; Bror Morein; D Burt
Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes.
The Journal of infectious diseases 1998;177(5):1266-74.
1998: Maria Villacres; S Behboudi; T Nikkila; Karin Lovgren-Bengtsson; Bror Morein
Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
Cellular immunology 1998;185(1):30-8.
1998: Jonathan Luke Heeney; ME van Gils; Peter H van der Meide; Carlo De Giuli Morghen; C Ghioni; M Gimelli; A Raddelli; David Davis; Lennart Akerblom; Bror Morein
The role of type-1 and type-2 T-helper immune responses in HIV-1 vaccine protection.
Journal of medical primatology 1998;27(2-3):50-8.
1998: M Johansson; Karin Lövgren-Bengtsson; A Sjölander; Bror Morein
Kinetics, localization and characteristics of B- and T-cell responses to iscoms containing human influenza virus glycoproteins.
Developments in biological standardization 1998;92():289-94.
1998: Bror Morein; M Villacrés-Eriksson; Karin Lövgren-Bengtsson
Iscom, a delivery system for parenteral and mucosal vaccination.
Developments in biological standardization 1998;92():33-9.
1997: B Rönnberg; M Fekadu; S Behboudi; Lennart Kenne; Bror Morein
Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
Vaccine 1997;15(17-18):1820-6.
1997: Izzeldin Abusugra; G Wolf; Göran Bölske; Francois Thiaucourt; Bror Morein
ISCOM vaccine against contagious bovine pleuropneumonia (CBPP). 1. Biochemical and immunological characterization.
Veterinary immunology and immunopathology 1997;59(1-2):31-48.
1997: David Davis; Bror Morein; Lennart Akerblom; Karin Lövgren-Bengtsson; ME van Gils; Willy M J M Bogers; Vera J P Teeuwsen; Jonathan Luke Heeney
A recombinant prime, peptide boost vaccination strategy can focus the immune response on to more than one epitope even though these may not be immunodominant in the complex immunogen.
Vaccine 1997;15(15):1661-9.
1997: S Behboudi; Bror Morein; Maria Villacres
In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.
Cytokine 1997;9(9):682-7.
1997: Gunilla A M Blomqvist; Lars Wesslén; Carl Påhlson; Eva Hjelm; B Pettersson; T Nikkilä; U Allard; O Svensson; M Uhlén; Bror Morein; Göran Friman
Phylogenetic placement and characterization of a new alpha-2 proteobacterium isolated from a patient with sepsis.
Journal of clinical microbiology 1997;35(8):1988-95.
1997: A Sjölander; Karin Lövgren Bengtsson; Bror Morein
Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
Vaccine 1997;15(9):1030-8.
1997: Suryaprakash Sambhara; S Woods; R Arpino; A Kurichh; A Tamane; Karin Lövgren Bengtsson; Bror Morein; BJ Underdown; M Klein; D Burt
Influenza (H1N1)-ISCOMs enhance immune responses and protection in aged mice.
Mechanisms of ageing and development 1997;96(1-3):157-69.
1997: Hernan Carol; A Nieto; Maria Villacres; Bror Morein
Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes.
Parasite immunology 1997;19(5):197-205.
1997: Eleni Dotsika; Evdokia Karagouni; B Sundquist; Bror Morein; A Morgan; Maria Villacres
Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms.
Scandinavian journal of immunology 1997;45(3):261-8.
1997: Maria Villacres; S Behboudi; A J Morgan; Trinchieri Giorgio; Bror Morein
Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response.
Cytokine 1997;9(2):73-82.
1996: Bror Morein; M Villacrés-Eriksson; A Sjölander; Karin Lövgren Bengtsson
Novel adjuvants and vaccine delivery systems.
Veterinary immunology and immunopathology 1996;54(1-4):373-84.
1996: A Nordengrahn; Miklós Rusvai; Malik Merza; J Ekström; Bror Morein; Sándor Belák
Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: prevention of the bifactorial disease with EHV-2 immunostimulating complexes.
Veterinary microbiology 1996;51(1-2):55-68.
1996: S Behboudi; Bror Morein; Maria Villacres
In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids.
Clinical and experimental immunology 1996;105(1):26-30.
1996: Anders Bolmstedt; S Sjölander; John-Erik Stig Hansen; Lennart Akerblom; A Hemming; Shiu-Lok Hu; Bror Morein; Sven-Olof Olofsson
Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(3):213-20.
1996: S Sjölander; John-Erik Stig Hansen; Karin Lövgren-Bengtsson; Lennart Akerblom; Bror Morein
Induction of homologous virus neutralizing antibodies in guinea-pigs immunized with two human immunodeficiency virus type 1 glycoprotein gp120-iscom preparations. A comparison with other adjuvant systems.
Vaccine 1996;14(4):344-52.
1996: A Sjölander; Karin Lövgren-Bengtsson; M Johansson; Bror Morein
Kinetics, localization and isotype profile of antibody responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins.
Scandinavian journal of immunology 1996;43(2):164-72.
1996: S Sjölander; Anders Bolmstedt; Lennart Akerblom; Peter Horal; Sven-Olof Olofsson; Bror Morein; A Sjölander
N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity.
Virology 1996;215(2):124-33.
1995: S Behboudi; Bror Morein; B Rönnberg
Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
Vaccine 1995;13(17):1690-6.
1995: B Rönnberg; M Fekadu; Bror Morein
Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
Vaccine 1995;13(14):1375-82.
1994: Malik Merza; E Larsson; M Steen; Bror Morein
Association of a retrovirus with a wasting condition in the Swedish moose.
Virology 1994;202(2):956-61.
1994: P Putkonen; Ewa Björling; Lennart Akerblom; Rigmor Thorstensson; K Lövgren; L Benthin; Francesca Chiodi; Bror Morein; Gunnel Biberfeld; E Norrby
Long-standing protection of macaques against cell-free HIV-2 with a HIV-2 iscom vaccine.
Journal of acquired immune deficiency syndromes 1994;7(6):551-9.
1994: Bror Morein; M Villacrés Eriksson; Lennart Akerblom; B Rönnberg; K Lövgren; A Sjölander
Mechanisms behind the immune response induced by immunostimulating complexes.
AIDS research and human retroviruses 1994;10 Suppl 2():S109-14.
1993: Maria Villacres; M Bergström-Mollaoglu; H Kåberg; K Lövgren; Bror Morein
The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.
Clinical and experimental immunology 1993;93(1):120-5.
1993: M Larsson; K Lövgren; Bror Morein
Immunopotentiation of synthetic oligopeptides by chemical conjugation to iscoms.
Journal of immunological methods 1993;162(2):257-60.
1993: A Sjölander; Stefan Ståhl; K Lövgren; Marianne Hansson; L Cavelier; A Walles; H Helmby; B Wåhlin; Bror Morein; M Uhlén
Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs).
Experimental parasitology 1993;76(2):134-45.
1993: Lennart Akerblom; P Nara; N Dunlop; S Putney; Bror Morein
HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
Biotechnology therapeutics 1993;4(3-4):145-61.
1992: M Bergström-Mollaoglu; K Lövgren; Lennart Akerblom; Caroline Fossum; Bror Morein
Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms.
Scandinavian journal of immunology 1992;36(4):565-74.
1992: Maria Villacres; M Bergström-Mollaoglu; H Kåberg; Bror Morein
Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms.
Scandinavian journal of immunology 1992;36(3):421-6.
1992: A Osterhaus; P de Vries; Bror Morein; Lennart Akerblom; Jonathan Luke Heeney
Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.
AIDS research and human retroviruses 1992;8(8):1507-10.
1992: Jonathan Luke Heeney; P de Vries; R Dubbes; W Koornstra; Henk Niphuis; Peter Ten Haaft; J Boes; ME Dings; Bror Morein; A D Osterhaus
Comparison of protection from homologous cell-free vs cell-associated SIV challenge afforded by inactivated whole SIV vaccines.
Journal of medical primatology 1992;21(2-3):126-30.
1992: D L Watson; N A Watson; Caroline Fossum; K Lövgren; Bror Morein
Interactions between immune-stimulating complexes (ISCOMs) and peritoneal mononuclear leucocytes.
Microbiology and immunology 1992;36(2):199-203.
1992: M Fekadu; JH Shaddock; J Ekström; A Osterhaus; D W Sanderlin; B Sundquist; Bror Morein
An immune stimulating complex (ISCOM) subunit rabies vaccine protects dogs and mice against street rabies challenge.
Vaccine 1992;10(3):192-7.
1991: Malik Merza; B Sundquist; J Söber; Bror Morein
Immunoaffinity purification of two major proteins of bovine leukemia virus (gp51 and p24) and their use for discrimination between vaccinated and infected animals.
Journal of virological methods 1991;33(3):345-53.
1991: Malik Merza; J Söber; B Sundquist; I Toots; Bror Morein
Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.
Archives of virology 1991;120(3-4):219-31.
1991: Bror Morein; Malik Merza
Vaccination against herpesvirus, fiction or reality?
Scandinavian journal of infectious diseases. Supplementum 1991;80():110-8.
1990: K Lövgren; H Kåberg; Bror Morein
An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration.
Clinical and experimental immunology 1990;82(3):435-9.
1990: Caroline Fossum; M Bergström; K Lövgren; D L Watson; Bror Morein
Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
Cellular immunology 1990;129(2):414-25.
1990: Bror Morein
The iscom: an immunostimulating system.
Immunology letters 1990;25(1-3):281-3.
1990: Bror Morein
Iscoms.
Veterinary microbiology 1990;23(1-4):79-84.
1990: Bror Morein; J Ekström; K Lövgren
Increased immunogenicity of a non-amphipathic protein (BSA) after inclusion into iscoms.
Journal of immunological methods 1990;128(2):177-81.
1990: Bror Morein; S Höglund
Subunit vaccines against infection by enveloped viruses.
Advances in biotechnological processes 1990;14():69-90.
1989: D L Watson; K Lövgren; N A Watson; Caroline Fossum; Bror Morein; S Höglund
Inflammatory response and antigen localization following immunization with influenza virus ISCOMs.
Inflammation 1989;13(6):641-9.
1989: Bror Morein; Sándor Belák; T Soós; Miklós Rusvai; B S McGwire; K Bognár
Iscom of viral envelope proteins protects against Aujeszky's disease.
Veterinary microbiology 1989;20(2):143-54.
1989: Lennart Akerblom; K Strömstedt; S Hoglund; A Osterhaus; Bror Morein
Formation and characterization of FeLV ISCOMs.
Vaccine 1989;7(2):142-6.
1989: S Höglund; K Dalsgaard; K Lövgren; B Sundquist; A Osterhaus; Bror Morein
ISCOMs and immunostimulation with viral antigens.
Sub-cellular biochemistry 1989;15():39-68.
1988: Caroline Fossum; A Burny; D Portetelle; M Mammerickx; Bror Morein
Detection of B and T cells, with lectins or antibodies, in healthy and bovine leukemia virus-infected cattle.
Veterinary immunology and immunopathology 1988;18(3):269-78.
1988: K Lövgren; Bror Morein
The requirement of lipids for the formation of immunostimulating complexes (iscoms).
Biotechnology and applied biochemistry 1988;10(2):161-72.
1988: Bror Morein
The iscom antigen-presenting system.
Nature 1988;332(6161):287-8.
1988: B Sundquist; K Lövgren; Bror Morein
Influenza virus ISCOMs: antibody response in animals.
Vaccine 1988;6(1):49-53.
1988: B Sundquist; K Lövgren; S Höglund; Bror Morein
Influenza virus ISCOMs: biochemical characterization.
Vaccine 1988;6(1):44-8.
1987: Bror Morein
Potentiation of the immune response by immunization with antigens in defined multimeric physical forms.
Veterinary immunology and immunopathology 1987;17(1-4):153-9.
1985: A Osterhaus; Kees Weijer; F Uytdehaag; O Jarrett; B Sundquist; Bror Morein
Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(1):591-6.
1984: Bror Morein; B Sundquist; S Höglund; K Dalsgaard; A Osterhaus
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.
Nature 1984;308(5958):457-60.